23andMe administrators renounce because the CEO of the genetic-testing corporate seeks to take it non-public
NEW YORK (AP) — All of 23andMe’s impartial administrators resigned from its board this week, an extraordinary transfer that marks the newest problem for the genetic-testing corporate.The resignations observe drawn-out negotiations with